Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
99.41
+3.52 (3.67%)
At close: Nov 14, 2025, 4:00 PM EST
99.00
-0.41 (-0.41%)
After-hours: Nov 14, 2025, 6:57 PM EST
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
The 12 analysts that cover Rhythm Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $117, which forecasts a 17.69% increase in the stock price over the next year. The lowest target is $94 and the highest is $142.
Price Target: $117 (+17.69%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 7 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 13 | 13 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $105 → $114 | Strong Buy | Maintains | $105 → $114 | +14.68% | Nov 10, 2025 |
| Needham | Needham | Strong Buy Maintains $122 → $120 | Strong Buy | Maintains | $122 → $120 | +20.71% | Nov 7, 2025 |
| Needham | Needham | Strong Buy Maintains $95 → $122 | Strong Buy | Maintains | $95 → $122 | +22.72% | Nov 4, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $157 → $139 | Strong Buy | Maintains | $157 → $139 | +39.82% | Oct 17, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $122 → $129 | Buy | Maintains | $122 → $129 | +29.77% | Oct 16, 2025 |
Financial Forecast
Revenue This Year
190.11M
from 130.13M
Increased by 46.10%
Revenue Next Year
309.91M
from 190.11M
Increased by 63.02%
EPS This Year
-3.07
from -4.34
EPS Next Year
-2.05
from -3.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 202.9M | 385.5M | |||
| Avg | 190.1M | 309.9M | |||
| Low | 176.3M | 259.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 55.9% | 102.8% | |||
| Avg | 46.1% | 63.0% | |||
| Low | 35.5% | 36.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.89 | -0.66 | |||
| Avg | -3.07 | -2.05 | |||
| Low | -3.34 | -3.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.